Browse the latest research summaries in the field of regenerative medicine for spinal cord injury patients and caregivers.
Showing 1,351-1,360 of 2,298 results
Bioactive Materials, 2024 • April 14, 2024
This review summarizes the characteristics of the dysfunctional pathological microenvironment in SCI, including inflammation, inhibitory biomolecules, and glial scar formation. Recent advances in biom...
KEY FINDING: Dysfunctional pathological microenvironment in SCI comprises excessive inflammation, deposition of inhibitory molecules, neurotrophic factor deprivation, glial scar formation, and imbalance of vascular function.
Stem Cell Research & Therapy, 2024 • May 26, 2024
This study investigated the efficacy of combination cell transplantation using BDNF-eMSC and iMNP in a chronic SCI rat model, aiming to improve motor function through neuron regeneration. The results ...
KEY FINDING: Combination cell transplantation of BDNF-eMSC and iMNP significantly improved behavioral recovery in a chronic SCI rat model compared to single-cell transplantation.
Neural Regen Res, 2025 • March 1, 2025
Spinal cord injury (SCI) results in permanent neurological disability and poses significant physical, financial, and psychological challenges. The complexity of SCI pathophysiology necessitates explor...
KEY FINDING: The combination of melatonin and dexamethasone showed suitable neuroprotective activities by reducing neutrophil infiltration, cytokine levels, tissue damage, inducible nitric oxide synthase expression, and apoptosis in SCI-treated mice, and motor recovery was also ameliorated.
J Vis Exp, 2024 • August 1, 2024
This study developed and characterized nerve-mimetic composite hydrogels to investigate the pro-regenerative behavior of adipose-derived stem cells for spinal cord injury repair. Successful decellular...
KEY FINDING: The decellularization process effectively removed cellular components from spinal cords and sciatic nerves while preserving the ECM structure.
Frontiers in Immunology, 2024 • June 11, 2024
This commentary provides additional considerations regarding the feasibility, efficacy, and safety of xenogeneic ovine bone marrow mesenchymal stem cells transplantation in SCI. The authors' research d...
KEY FINDING: Xenogeneic sheep bone marrow MSCs can engraft at the injury site in a rat SCI model.
Frontiers in Molecular Neuroscience, 2024 • June 17, 2024
This editorial discusses the challenges and potential therapeutic approaches for restoring neural circuits after spinal cord injury (SCI). Various strategies, including stem cell therapies, microRNAs,...
KEY FINDING: iPSCs have the potential to differentiate into neurons, astrocytes, and oligodendrocytes, replacing damaged cells, regulating the spinal cord microenvironment, and promoting axon and myelin sheath regeneration.
Apoptosis, 2016 • October 1, 2016
The use of human PBMCs as bioreactors for secretome-based therapies can be seen as an extension of the original concept of stem cell-based therapies to enable clinical applications. Using apoptotic PB...
KEY FINDING: Apoptotic PBMCs attenuated LPS-induced spillage of IL-6 and IL-1β in co-cultured monocytes and PBMCs. Irradiated PBMCs reduced T-cell proliferation.
Stem Cell Research & Therapy, 2024 • July 2, 2024
SCI is a complex condition that results in significant functional and anatomical changes within the spinal cord. NSCs represent a promising regenerative strategy for SCI treatment due to their ability...
KEY FINDING: NSCs represent a promising regenerative strategy for SCI treatment due to their ability to differentiate into neurons and glial cells, of which, oligodendrocytes play a crucial role in myelin regeneration, demyelination repair and neural circuit reconstruction.
iScience, 2024 • July 19, 2024
This theoretical study investigated whether the regeneration-inducing signal can follow a reaction-diffusion process, developing a computational model validated with experimental data. The study demon...
KEY FINDING: Spinal cord regeneration can be explained by a potential signaling mechanism operating under a reaction-diffusion scheme.
Advanced Science, 2024 • July 18, 2024
The study introduces an osteoimmunity-regulating biopatch designed to enhance stem cell-based bone regeneration. The patch incorporates bioactive nano micelles (PPT NMs) that modulate IL-17 signaling ...
KEY FINDING: PPT NMs effectively mitigated LPS-stimulated cell apoptosis, in a dose-dependent manner, suggesting an anti-apoptotic effect.